Page 17 - P4304.1-V97_PS-Magazine-May 2024
P. 17

NEW


            Up to 23% discount
 STRENGTH


 Abbreviated Prescribing Information: Omeprazole 1 mg/
 ml,  Powder  for  Oral  Suspension. Consult Summary of
 Product Characteristics before prescribing. Presentation:
 White/off-white/slightly  yellow  powder,  each  ml  of
 reconstituted  suspension  contains  1  mg  of  omeprazole.
 Therapeutic Indications:  Omeprazole  Oral  Suspension  is   Across the complete
 indicated for treatment of refl ux esophagitis; Symptomatic
 treatment of heartburn and acid regurgitation in gastro-
 esophageal  refl ux  disease  in  children  aged  1  –  12
 months of age. Posology and Method of Administration:
 Omeprazole Oral Suspension should be taken on an empty
 stomach  following  reconstitution,  at  least  30  minutes   Scope prescription range
 before a meal. The oral suspension should not be mixed
 or administered with any drinks or foods other than milk.
 Omeprazole  can  be    administered  via  nasogastric  (NG)
 or  percutaneous  endoscopic  gastrostomy  (PEG)  tubes.
 Paediatric population aged 1 month to 12 months:
 Omeprazole 1 mg/ml oral suspension should be used for
 patients weighing ≥ 2 kg to ≤ 5 kg. 1 mg/kg body weight   PIP Code  Product  NHS Price  Rebate  WD    Net       Profit
 once daily is recommended. Individual dose measurements
 ≤ 2 ml are not indicated. The treatment time is 4-8 weeks   4259354  Hylo-Dual Intense Eye  Drops (10ml)  £9.95  23%  10%  £6.67  £3.28
 for refl ux esophagitis and 2–4 weeks for heartburn and
 acid  regurgitation  in  gastro-esophageal  refl ux  disease.   4241329  Codimaz 20mcg/5mg/ml Eye Drops (5ml)  £8.03  22%  0%  £6.26  £1.77
 Dose adjustment is not needed in patients with impaired
 renal  function. Contraindications:  Hypersensitivity  to  the   4241311  Diamaz 20mg/ml Eye Drops (5ml)  £6.98  22%  0%  £5.44  £1.54
 active substance, substituted benzimidazoles or to any of
 the excipients listed and concomitant use with nelfi navir.   4227344  Bimi 0.3mg/ml Eye Drops (3ml)  £8.33  22%  0%  £6.50  £1.83
 Special Warnings and Precautions for use: Caution should
 be  exercised  when  used  as  Omeprazole  may  alleviate   4227351  Bimi 0.3mg/ml Eye Drops (9ml)  £21.87  22%  0%  £17.06  £4.81
 symptoms of malignancy and delay diagnosis. Concomitant
 use with atazanavir is not recommended. Omeprazole may   3488368  Hylo-Forte 0.2% (10ml)  £9.50  15%  10%  £7.13  £2.38
 reduce the absorption of vitamin B12 and the potential for
 interactions with drugs metabolised through CYP2C19 should   3472925  Hylo-Tears 0.1% (10ml)  £8.50  15%  10%  £6.38  £2.13
 be considered. Severe hypomagnesaemia has been reported
 in patients treated with proton pump inhibitors (PPIs) like   3552999  Hylo-Care Eye Lubricant (10ml)  £10.30  15%  10%  £7.73  £2.58
 omeprazole for at least three months, and in most cases
 for a year. Increased risk of hip, wrist and spine fracture
 in high doses and over long durations (>1 year) should be   3866688  Hylo-Fresh 0.03% (10ml)  £4.95  15%  10%  £3.71  £1.24
 considered. Severe cutaneous adverse reactions are reported
 in association with omeprazole treatment. Treatment should   4045175  Hylo-Dual Eye Drops (10ml)  £9.95  15%  10%  £7.46  £2.49
 be discontinued in case of suspected acute tubulointerstitial
 nephritis  and  subacute  cutaneous  lupus  erythematosus.   4075099  Ketofall 0.25mg/ml UD Vials (30x0.4ml)   £6.95  15%  10%  £5.21  £1.74
 Omeprazole  treatment  should  be  stopped  for  at  least
 5  days  before  Increased  Chromogranin  measurements.   3692357  Tear-Lac Drops 0.3% (10ml)  £5.75  15%  10%  £4.31  £1.44
 Slightly  increased  risk  of  gastrointestinal  infections  such
 as  Salmonella  and  Campylobacter  are  associated  with   4149563  Hylo-Night Pf Eye Oint (5g)  £2.75  15%  10%  £2.06  £0.69
 proton pump inhibitors. Care should be exercised in patients
 with reduced kidney function or patients on a controlled   4156923  EvoTears (3ml)  £9.95  15%  10%   £7.46     £2.49
 potassium diet as this medicine contains 54.3 mg (1.39   Making a happy difference for babies
 mmol) potassium per ml or 271.5 mg (6.95 mmol) of   3500295  ComplEye Eye Drop Dispenser  £2.00  15%  10%  £1.50  £0.50
 potassium per 5 ml dose. Allergic reactions may be caused
 *
 by  the  excipient  sodium  methyl  para  hydroxybenzoate.   4039731  Optase Moist Heat Mask  £5.53  15%  10%  £4.15  £1.38
 Risk  for  neonatal  jaundice  should  be  considered  and   with GORD  and their parents
 patients  with  fructose  intolerance  should  not  take  this
 medicine as it contains maltitol. Any warning from the   Scope loyalty rewards scheme:
 MC, CHM CSM or MHRA. No. Black Triangle notice (if
 relevant):  N/A.  Legal Category:  POM.  The reported   A new 1mg/ml strength of licensed liquid  Scope Eyecare’s prescription product range is now available
 adverse reactions are:  Leukopenia,  thrombocytopenia,
 Agranulocytosis,  pancytopenia,  Hypersensitivity  reactions   omeprazole for babies from 1-12 months
 e.g. fever, angioedema and anaphylactic reaction/shock,   with MDS discount plus applicable wholesaler discount.
 Hyponatraemia,  Hypomagnesaemia;  hypocalcaemia,
 hypokalaemia, Insomnia, Agitation, confusion, depression,   Developed specifi cally to meet the needs of babies over one
 Aggression,   hallucinations,   Headache,   Dizziness,
 paraesthesia, somnolence, Taste disturbance, Blurred vision,   month who suffer with GORD, Omeprazole 1mg/ml Powder
 Vertigo,  Bronchospasm,  Abdominal  pain,  constipation,
 diarrhoea, fl atulence, nausea/vomiting, fundic gland polyps   for Oral Suspension is an extension to Rosemont’s innovative
 (benign), Dry mouth, stomatitis, gastrointestinal candidiasis,
 Microscopic colitis, Increased liver enzymes, Hepatitis with   range of licensed liquid omeprazole products. The product has a
 or  without  jaundice,  Hepatic  failure,  encephalopathy  in
 patients with pre-existing liver disease, Dermatitis, pruritus,   natural Strawberry fl avour. Strawberry fl avour is most
 rash, urticaria, Alopecia, photosensitivity, acute generalized
 exanthematous  pustulosis  (AGEP),  drug  reaction  with   popular with children.  The new strength is unique
 1
 eosinophilia  and  systemic  symptoms  (DRESS),  Erythema
 multiforme,  Stevens-Johnson  syndrome,  toxic  epidermal   in that it can be mixed with a small quantity of baby’s
 necrolysis (TEN), Subacute cutaneous lupus erythematosus,
 Fracture  of  the  hip,  wrist  or  spine,  Arthralgia,  myalgia,   milk to make administration easier. View our video
 Muscular  weakness,  Tubulointerstitial  nephritis  (with
 possible  progression  to  renal  failure),  Gynaecomastia,   Scan to see   guide to constitution via the QR code or for more
 Malaise,  peripheral  oedema,  Increased  sweating.  Pack   constitution
 Size and NHS Price:  Each  bottle  contains  90ml  of   video  information, visit www.rosemontpharma.com
 oral  suspension  of  which  at  least  75ml  is  intended  for
 dosing-  £111.00.  Marketing Authorisation Number:  PL
 34111/0005.  Marketing Authorisation Holder:  Xeolas
 Pharmaceuticals Limited, Hamilton Building, DCU, Glasnevin,   *Gastro oesophageal refl ux disease
 Dublin 9, Ireland. Date of Preparation: July 2023.    Information and pricing correct at time of going to print.
 Reference 1. Generation R. What fl avour would children   Rosemont Pharmaceuticals Ltd. Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds LS11 9XE  T +44 (0)113 244 1400  F +44 (0)113 245 3567   For full terms and conditions, please visit psuk.co.uk
 choose  for  their  medicine?  Available  at:  https://  E infodesk@rosemontpharma.com  Sales/Customer Service:  T +44 (0) 113 244 1999  F +44 (0) 113 246 0738  W www.rosemontpharma.com
 generationr.org.uk/what-fl avour-would-children-choose-
 for-their-medicines/  Accessed August 2023.   Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard  Adverse events should also be reported to Rosemont Pharmaceuticals Ltd on 0113 244 1400.
 ROS000019-001 September 2023
         P4304.1-V97_PS-Magazine-May 2024.indd   17                                                              15/04/2024   11:42:37
         P4304.1-V97_PS-Magazine-May 2024.indd   17
                                                                                                                 15/04/2024   11:42:37
 ROS000019-001 Omeprazole Paediatric A4 Ad.indd   1  03/10/2023   15:38
 03/10/2023   15:38
 ROS000019-001 Omeprazole Paediatric A4 Ad.indd   1
   12   13   14   15   16   17   18   19   20   21   22